Blair William & Co. IL Boosts Position in Stevanato Group S.p.A. (NYSE:STVN)

Key Points

• Blair William & Co. IL increased its holdings in Stevanato Group by 642.9%, acquiring an additional 137,625 shares in the first quarter, resulting in a total of 159,032 shares worth approximately $3.25 million.
• Stevanato Group's stock is currently valued at €24.20 ($28.14), with a market cap of $7.33 billion and a 12-month price range from €17.12 to €28.00.
• Analysts maintain a consensus rating of "Moderate Buy" for Stevanato Group, with a consensus price target of €25.13 ($29.22).

Blair William & Co. IL raised its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 642.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 159,032 shares of the company's stock after acquiring an additional 137,625 shares during the quarter. Blair William & Co. IL owned approximately 0.05% of Stevanato Group worth $3,247,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of the business. Bessemer Group Inc. lifted its stake in Stevanato Group by 14,623.3% in the 1st quarter. Bessemer Group Inc. now owns 13,251 shares of the company's stock worth $270,000 after purchasing an additional 13,161 shares in the last quarter. Palisade Capital Management LP boosted its stake in shares of Stevanato Group by 52.0% during the 1st quarter. Palisade Capital Management LP now owns 91,431 shares of the company's stock valued at $1,867,000 after purchasing an additional 31,283 shares in the last quarter. D. E. Shaw & Co. Inc. bought a new stake in shares of Stevanato Group during the 4th quarter valued at about $281,000. Envestnet Asset Management Inc. boosted its stake in shares of Stevanato Group by 16.9% during the 1st quarter. Envestnet Asset Management Inc. now owns 162,770 shares of the company's stock valued at $3,324,000 after purchasing an additional 23,545 shares in the last quarter. Finally, Yarbrough Capital LLC bought a new stake in shares of Stevanato Group during the 1st quarter valued at about $329,000.

Analyst Ratings Changes

Several research analysts have issued reports on the stock. William Blair reaffirmed an "outperform" rating on shares of Stevanato Group in a report on Monday, June 30th. Stephens upgraded shares of Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. Two research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Stevanato Group has a consensus rating of "Moderate Buy" and a consensus price target of €25.13 ($29.22).

Stevanato Group Price Performance

Stevanato Group stock traded down €0.04 ($0.05) during mid-day trading on Tuesday, reaching €21.81 ($25.36). 163,687 shares of the company's stock traded hands, compared to its average volume of 340,223. The company has a market cap of $6.60 billion, a price-to-earnings ratio of 40.39, a PEG ratio of 2.23 and a beta of 0.55. The stock has a 50 day moving average of €24.52 and a two-hundred day moving average of €22.45. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25. Stevanato Group S.p.A. has a 12-month low of €17.12 ($19.91) and a 12-month high of €28.00 ($32.56).

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.